In this group of patients, (48%) were between 21-30 years, nearly two-thirds (64%) were women
References Chen SS, Wright NT, Humphrey JD
The absence of effective conventional options increases the relative risk tolerance for an unvalidated compound in the treatment-resistant population
Best peptides for back pain ranked by effectiveness Based on mechanism of action, available research, and practical experience from the peptide community, these peptides offer the most promise for back pain conditions
Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG , Low DE, Hofstetter WL